UiPath Inc.

Informe acción NYSE:PATH

Capitalización de mercado: US$11.0b

Salud financiera de hoja de balance de UiPath

Salud financiera controles de criterios 6/6

UiPath tiene un patrimonio de los accionistas total de $2.0B y una deuda total de $0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son $3.0B y $938.6M respectivamente.

Información clave

0%

Ratio deuda-patrimonio

US$0

Deuda

Ratio de cobertura de interesesn/a
EfectivoUS$1.88b
PatrimonioUS$2.02b
Total pasivoUS$938.64m
Activos totalesUS$2.95b

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

UiPath: A Hold Based On Demystifying The AI Hype (Rating Downgrade)

Apr 24

UiPath: Still Unloved

Apr 18

UiPath: Post-Earnings Selloff Is A Gift, Positive GAAP Income, Net Cash (Upgrade)

Mar 20

Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

Feb 28
Why Investors Shouldn't Be Surprised By UiPath Inc.'s (NYSE:PATH) P/S

UiPath: I Am Not Ready To Pay Premium Here

Feb 19

Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

Feb 01
Is UiPath Inc. (NYSE:PATH) Potentially Undervalued?

UiPath: Leader In An Unloved Segment

Jan 16

UiPath's Bots Make Generative AI Apps Work Better

Jan 09

UiPath: From IPO Hype To Market Leadership, And Challenges Ahead

Dec 29

A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

Nov 27
A Look At The Fair Value Of UiPath Inc. (NYSE:PATH)

UiPath: Correction Over; Outperformance Ahead

Nov 26

UiPath May Beat Expectations Again, Staying Expensive

Nov 20

UiPath: Left Underappreciated

Oct 16

UiPath: The Real AI Pioneer

Sep 14

UiPath Q2 2024 Earnings Preview: I Expect FY24 Guidance To Be Raised

Sep 05

UiPath: AI Revolution In RPA - Major Growth Potential

Aug 18

Is UiPath Inc. (NYSE:PATH) Worth US$16.2 Based On Its Intrinsic Value?

Aug 08
Is UiPath Inc. (NYSE:PATH) Worth US$16.2 Based On Its Intrinsic Value?

UiPath - Not Yet A Buy, But Keep It On Your Watchlist

Aug 07

UiPath: Sitting Above The Tech Stack

Jul 20

UiPath: Path To Positive FCF Getting Clearer

Jul 07

UiPath: AI Competition Increases

Jun 08

UiPath: Margin Improvements Are Supporting The Stock

May 31

UiPath Inc.'s (NYSE:PATH) Price In Tune With Revenues

Apr 17
UiPath Inc.'s (NYSE:PATH) Price In Tune With Revenues

UiPath: Weak Growth Could Overwhelm Improving Profitability

Feb 17

UiPath An Overvalued AI Software Developer Company

Feb 07

UiPath: I Know It's Bad, But So Do You

Jan 23

UiPath: Still Not A Buy

Dec 23

UiPath Inc. (NYSE:PATH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Dec 05
UiPath Inc. (NYSE:PATH) Just Released Its Third-Quarter Results And Analysts Are Updating Their Estimates

Estimating The Intrinsic Value Of UiPath Inc. (NYSE:PATH)

Nov 29
Estimating The Intrinsic Value Of UiPath Inc. (NYSE:PATH)

UiPath: Why I Am Not Buying The Dip Yet

Nov 13

UiPath: Itching For A Rally

Oct 18

UiPath's Path To Higher Stock Price Will Likely Come To Pass

Oct 05

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($2.6B) de PATH superan a sus pasivos a corto plazo ($711.7M).

Pasivo a largo plazo: Los activos a corto plazo de PATH ($2.6B) superan a sus pasivos a largo plazo ($227.0M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: PATH está libre de deudas.

Reducción de la deuda: PATH no ha tenido ninguna deuda en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable PATH tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: PATH no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 87.8% al año.


Descubre empresas con salud financiera

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target